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ABSTRACT 
 
On the basis of literature review Semicarbazones have been potent in activities such as 
antifungal, antibacterial, antituberculosis, anticancerous etc.   Till date various works has been 
done however still there is tremendous opportunities which can be explored. So, we planned 
for the synthesis of Semicarbazone derivaties and checking their antimicrobial activities. 
Biological activity was determined for all 19 synthesized compounds against bacteria (gram 
positive and gram negative) by MIC(Minimum Inhibitory Concentration) method. 
 
Introduction
The discovery, development, and clinical use of antibiotics 
during the 20th century have decreased substantially the 
morbidity and mortality from bacterial infections. The 
antibiotic era began with the therapeutic application of 
sulphonamide drugs in the 1930s, followed by a “golden” 
period of discovery from approximately 1945 to 1970, when a 
number of structurally diverse, highly effective agents were 
discovered and developed [1]. The currently available 
antibiotics includes β-lactums (Penicillin and Cephalosporins), 
Aminoglycosides, Tetracyclines, Chloramphenicol, Macrolids, 
lincosamides, Sulfonamides, Sulfones, Quinolones/ 
Fluoroquinolones, Metronidazole, Nitrofurantoin, Fucidin and 
Vancomycin.  All these agent causes severe to moderate side 
effects. Moreover, since the 1980s the introduction of new 
agents for clinical use has declined, reflecting both the 
challenge of identifying new drug classes and a declining 
commitment to antibacterial drug discovery by the 
pharmaceutical industry [2]. The same period with a reduced 
rate of introduction of new agents has been accompanied by 
an alarming increase in bacterial resistance to existing agents, 
resulting in the emergence of a serious threat to global public 
health [3]. Resistance to current clinically available antibiotics 
is now major setback in the treatment of infectious disease [4]. 
Recently in India there was a report of some newer resistant 
superbugs or MDR (multi drug resistance) causing intense 
economic loss in medical tourism [5]. These are making 
medications less effective in both prophylactic and treatment 
of infections [6]. Antimicrobial resistance is now growing 
problem in world and causes millions of deaths every years 
[7].  There have been increasing public calls for global 
collective action to address the threat. The resistance problem 
demands that a renewed effort be made to seek antibacterial 
agents effective against pathogenic bacteria resistant to current 
antibiotics. All these factors are pressing the needs to develop 
some newer antimicrobial agents having different structural 
scaffold acting through different mechanisms. Semicarbazones 
belong to an important structural class, which have valuable 
and diverse biological properties.
 
Semicarbazones are 
extensively used as synthetic intermediates [8]. They have 
been used to synthesize various heterocyclic compounds 
which have wide ranges of pharmacological activities,
 
for 
example anticonvulsant [9], antibacterial [10], antifungal [11], 
antitubercular [12] and anticancer [13] activities. Keeping all 
these in mind we have designed and synthesise some newer 
semicarbazone derivatives as potential antimicrobial agents. 
 
Experimental 
Instrumentation 
The entire chemical reagents which are used in the study are 
procured locally. The completion of reaction is monitored by 
thin layer chromatography (TLC) using chloroform-methanol 
(9:1) as the solvent system. The products were purified by 
recrystallisation with absolute ethanol and purity of the 
compounds was checked by thin layer chromatography (TLC) 
using silica gel G plates (Merck). The spot was developed in 
iodine chamber or viewed under UV lamp. Melting points 
were determined in an open capillary using melting point 
apparatus and are uncorrected. The proton magnetic 
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resonance(1H NMR) spectra were recorded on a Brucker 300 
MHz instrument in DMSOd6 using tetramethylsilane as an 
internal standard. The infrared spectra of compounds were 
recorded in KBr on a Bio-Rad FTIR Spectrophotometer. 
General procedure for the synthesis of (2E)-2-
(substitutedbenzylidene)-N-(3-chloro-4-methoxyphenyl) 
hydrazinecarboxamide (3a–s). Synthesis of semicarbazones 
were carried out by the earlier reported procedure. A mixture 
of semicarbazide (0.01 mole) and aldehydes or ketones (0.01 
mole) were refluxed in presence of sodium acetate and HCl (2 
ml) in alcohol. The completion of reactions was monitored by 
TLC using benzene: acetone (7:3) as the mobile phase. 
 
(2E)-2-(2-chlorobenzylidene)-N-(3-chloro-4-methoxy 
phenyl)hydrazinecarboxamide (3a). Yield 74%; m.p. 175; IR 
(KBr) cm
-1
: 3375 (N-H), 1675(C=O), 1534 (C=N); 1H; NMR 
(DMSO-d6) δ ppm: 3.83 (s, 3H, OCH3), 6.89–7.85(m, 7H, 
aromatic), 7.64 (s, 1H, N=CH), 9.00 (s, 1H, Ar–NH), 10.62 (s, 
1H, CONH); MS: m/z, M+ 338; Anal. Calcd for 
C15H13Cl2N3O2  : C 53.27 ; H 3.87 ; Cl 20.97 ; N 12.43 ; O 
9.46 Found: C 53.17 ; H 3.88 ; N 12.45 ; O 9.48. 
 
(2E)-2-(4-chlorobenzylidene)-N-(3-chloro-4-methoxy 
phenyl)hydrazinecarboxamide (3b)  
Yield 71%; m.p. 188 _C, IR (KBr) cm
-1
: 3405 (N-H), 1701 
(C=O), 1540 (C=N) ; 1H NMR (DMSO-d6) δ ppm3.81 (s, 3H, 
OCH3), 6.84–7.82(m, 7H, aromatic), 7.61 (s, 1H, N=CH), 8.99 
(s, 1H, Ar–NH), 10.60(s, 1H, CONH) ; MS: m/z, M+ 325 ; 
Anal. Calcd for C15H13Cl2N3O2 : C 53.27 ; H 3.87 ;  Cl 20.97 ; 
N 12.43 ; O 9.46. Found: C 53.17 ; H 3.88 ; N 12.45 ;  O 9.48. 
 
(2E)-N-(3-chloro-4-methoxyphenyl)-2-(2-nitrobenzyl 
idene)hydrazinecarboxamide (3c)  
Yield 74%; m.p. 217 _C, IR (KBr) cm
-1
: 3406 (N-H), 
1695(C=O), 1531 (C=N) ; 1H NMR (DMSO-d6) δ ppm 3.79 
(s, 3H, OCH3), 6.82–7.80(m, 7H, aromatic), 7.59 (s, 1H, 
N=CH), 8.98 (s, 1H, Ar–NH), 10.59(s, 1H, CONH);   MS: 
m/z, M+ 348.74 Anal. Calcd for C15H13ClN4O4 : C 51.66 ; H 
3.76 ; Cl 10.17 ; N 16.07 ; O 18.35. Found: C 51.62 ; H 3.77 ; 
N 12.47 ; O  9.49. 
 
(2E)-N-(3-chloro-4-methoxyphenyl)-2-(4-nitro 
benzylidene)hydrazine carboxamide (3d)  
 Yield 66%; m.p. 197 _C, IR (KBr) cm
-1
: 3408 (N-H), 1699 
(C=O), 1536 (C=N); 1H NMR (DMSO-d6) δ ppm 3.80 (s, 3H, 
OCH3), 6.83–7.81(m, 7H, aromatic), 7.62 (s, 1H, N=CH), 
8.99(s, 1H, Ar–NH), 10.60(s, 1H, CONH); MS: m/z, M+ 
348.74, Anal. Calcd for C15H13ClN4O4 :  C 51.66 ; H 3.76 ; Cl 
10.17 ; N 16.07 ; O 18.35. Found: C 51.62 ; H 3.77 ; N 12.47 ; 
O 9.49. 
(2E)-N-(3-chloro-4-methoxyphenyl)-2-(2-hydroxy 
benzylidene)hydrazinecarboxamide (3e) 
Yield 56%; m.p. 171_C, IR (KBr) cm
-1
: 3380 (N-H), 1681 
(C=O), 1541 (C=N) ; (DMSO-d60) δ ppm 3.81 (s, 3H, OCH3), 
6.84–7.82(m, 7H, aromatic), 7.63 (s, 1H, N=CH), 9.00(s, 1H, 
Ar–NH), 10.61(s, 1H, CONH) ; MS: m/z, M+ 319.74 ; Anal. 
Calcd for C15H14ClN3O3 : C 56.35 ; H 4.41 ;  Cl 11.09 ; N 
13.14 ; O 15.01. Found: C 56.36 ;  H 4.43 ; Cl 11.08 ; N 13.16 
; O 15.02. 
(2E)-N-(3-chloro-4-methoxyphenyl)-2-(4-hydroxyl 
benzylidene)hydrazinecarboxamide (3f) Yield 65%; m.p. 201 
_C, IR (KBr) cm
-1
: 3385 (N-H), 1685 (C=O), 1546 (C=N) ; 
(DMSO-d6); δ ppm 3.83 (s, 3H, OCH3), 6.86–7.84(m, 7H, 
aromatic), 7.65 (s, 1H, N=CH), 9.02(s, 1H, Ar–NH), 10.63(s, 
1H, CONH) ; MS: m/z, M+ 319.74 ; Anal. Calcd for 
C15H14ClN3O3 : C 56.35 ;  H 4.41 ;   Cl 11.09 ; N 13.14 ; O 
15.01. Found: C 56.36 ;  H 4.43 ;  Cl 11.08 ; N 13.16 ; O 
15.02. 
(2E)-N-(3-chloro-4-methoxyphenyl)-2-(4-methoxy 
benzylidene)hydrazinecarboxamide (3g) 
Yield 69%; m.p. 144 _C, IR (KBr) cm
-1
: 3375 (N-H), 1682 
(C=O), 1541 (C=N) ; (DMSO-d6); δ ppm : 3.83 (s, 3H, 
OCH3), 6.86–7.84(m, 7H, aromatic), 7.65 (s, 1H, N=CH), 
9.02(s, 1H, Ar–NH), 10.63(s, 1H, CONH); MS: m/z, M+ 
333.76; Anal. Calcd for C16H16ClN3O3 : C 57.58 ;  H 4.83 ;  Cl 
10.62 ; N 12.59 ; O 14.38. Found: C 57.59 ;  H 4.44 ;  Cl 
11.09 ; N 13.17 ; O 15.03. 
(2E)-N-(3-chloro-4-methoxyphenyl)-2-(3,4-dimethoxy 
benzylidene) hydrazinecarboxamide (3h) Yield 67%; m.p. 
200 _C, IR (KBr) cm
-1
: 3365 (N-H), 1693 (C=O), 1551 (C=N) 
; (DMSO-d6) δ ppm : 3.84 (s, 3H, OCH3), 6.87–7.85(m, 6H, 
aromatic), 7.66 (s, 1H, N=CH), 9.03(s, 1H, Ar–NH), 10.64(s, 
1H, CONH); MS: m/z, M+ 363.79 ; Anal. Calcd for 
C17H18ClN3O4 : C 56.13 ; H 4.99 ; Cl 9.75 ; N 11.55 ; O 17.59. 
Found: C 56.14 ; H  4.98 ;  Cl 11.56 ;  N 11.56 ; O 17.60. 
 
(2E)-N-(3-chloro-4-methoxyphenyl)-2-[4-(dimethyl 
amino)benzylidene]hydrazinecarboxamide (3i) Yield 66%; 
m.p. 179 _C, IR (KBr) cm
-1
: 3375 (N-H), 1683 (C=O), 1581 
(C=N); (DMSO-d6) δ ppm : 3.85 (s, 3H, OCH3), 6.88–7.86(m, 
7H, aromatic), 7.67 (s, 1H, N=CH), 9.04(s, 1H, Ar–NH), 
10.65(s, 1H, CONH); MS: m/z M+ 346.81; Anal. Calcd for 
C17H19ClN4O2 : C 58.87 ;  H 5.52 ;  Cl 10.22 ; N 16.15 ; O 
9.23. Found: C 58.88 ; H 5.53;  Cl 10.23 ; N 16.16 ; O 9.22. 
 
(2E)-N-(3-chloro-4-methoxyphenyl)-2-[1-(2,4-
dichlorophenyl)ethylidene]hydrazinecarbox-amide (3j) Yield 
64%; m.p.145 _C, IR (KBr) cm
-1
: 3370 (N-H), 1683 
(C=O),1543 (C=N); (DMSO-d6) δ ppm : 3.85 (s, 3H, OCH3), 
6.88–7.86(m, 6H, aromatic), 7.67 (s, 1H, N=CH), 9.04(s, 1H, 
Ar–NH), 10.65(s, 1H, CONH); MS: m/z, M+ 386.66; Anal. 
Calcd for C16H14Cl3N3O2 : C 49.70 ; H 3.65 ; Cl 27.51 ; N 
10.87 ;  O 8.28. Found: C 49.71 ; H 3.66  ; Cl 27.52 ;  N 10.88 
; O 8.29. 
(2E)-N-(3-chloro-4-methoxyphenyl)-2-[1-(4-hydroxy 
phenyl)ethylidene]hydrazinecarbox-amide(3k)  Yield 63%; 
m.p. 178 _C, IR (KBr) cm
-1
: 3381(N-H), 1681(C=O), 
1553(C=N); (DMSO-d6) δ ppm : 3.86 (s, 3H, OCH3), 6.87–
7.87(m, 7H, aromatic), 7.68(s, 1H, N=CH), 9.05(s, 1H, Ar–
NH), 10.66(s, 1H, CONH) ; MS: m/z, M+ 333.76; Anal. Calcd 
for C16H16ClN3O3 : C 57.58 ; H 4.83 ; Cl 10.62 ; N 12.59 ; O 
14.38. Found: C 57.59 ; H 3.27 ; Cl 28.57  ;  N 11.28  ; O 
8.61. 
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(2E)-N-(3-chloro-4-methoxyphenyl)-2-[1-(4-
methoxyphenyl)ethylidene]hydrazinecarbox-amide(3l) Yield 
72%; m.p.132 _C, IR (KBr) cm
-1
: 3378 (N-H), 1691 (C=O), 
1533 (N=C); (DMSO-d6); δ ppm : 3.85 (s, 3H, OCH3), 6.86–
7.86(m, 7H, aromatic), 7.69(s, 1H, N=CH), 9.05(s, 1H, Ar–
NH), 10.67(s, 1H, CONH) ; MS: m/z, (M+) 347.796 ; Anal. 
Calcd for C17H18ClN3O3 : C 57.58 ; H 4.83 ; Cl 10.62 ; N 
12.59 ; O 14.38. Found: C 58.71 ; H 5.22 ;  Cl 10.19 ; N 12.08 
; O 13.80. 
(2E)-N-(3-chloro-4-methoxyphenyl)-2-[1-(4-chloro 
phenyl)ethylidene]hydrazinecarbox-amide(3m) Yield 68%; 
m.p.265 _C, IR (KBr) cm
-1
: 3374 (N-H), 1674 (C=O), 
1546(C=N); (DMSO-d6) δ ppm : 3.86 (s, 3H, OCH3), 6.87–
7.87(m, 7H, aromatic), 7.70(s, 1H, N=CH), 9.06(s, 1H, Ar–
NH), 10.68(s, 1H, CONH); MS: m/z, M+ 352.21; Anal. Calcd 
for C16H15Cl2N3O2.: C 54.56 ; H 4.29 ;  Cl 20.13 ; N 11.93 ; O 
9.09.Found: C 54.57 ; H 4.30 ; Cl 20.14 ; N 11.94 ; O 9.10. 
(2E)-N-(3-chloro-4-methoxyphenyl)-2-[1-(4-
nitrophenyl)ethylidene]hydrazinecarboxamide(3n)Yield 
68%; m.p. 182 _C, IR (KBr) cm
-1
: 3365 (N-H), 1684 (C=O), 
1555 (C=N); (DMSO-d6) δ ppm : 3.87 (s, 3H, OCH3), 6.88–
7.88(m, 7H, aromatic), 7.71(s, 1H, N=CH), 9.07(s, 1H, Ar–
NH), 10.69(s, 1H, CONH); MS: m/z, M+ 362.77; Anal. Calcd 
for C16H15ClN4O4 : C 52.97 ; H 4.17; Cl 9.77 N 15.44  O 17.64 
Found: C 57.96 ; H 4.16 ; Cl 9.78 ;  N 15.43 ; O 17.65. 
 
(2E)-N-(3-chloro-4-methoxyphenyl)-2-[1-(4-methyl 
phenyl)ethylidene]hydrazinecarboxamide (3o)Yield 70%; 
m.p. 174 _C, IR (KBr) cm
-1
: 3374 (N-H), 1680 (C=O), 1584 
(C=N); (DMSO-d6) δ ppm : 3.87 (s, 3H, OCH3), 6.88–7.88(m, 
7H, aromatic), 7.71(s, 1H, N=CH), 9.07(s, 1H, Ar–NH), 
10.69(s, 1H, CONH); MS: m/z, M+ 331.79; Anal. Calcd for 
C17H18ClN3O2 : C 61.54 ; H 5.47 ; Cl ; 10.69 N ; 12.66 ; O 
9.64 Found: C 61.55 H ; 5.48 ; Cl 10.71; N 12.67 ; O 9.65. 
(2E)-2-(4-chlorobenzylidene)-N-(2-methoxyphenyl) 
hydrazinecarboxamide (3p) 
 Yield 70%; m.p. 178  _C, IR (KBr) cm
-1
: 3382 (N-H), 1690 
(C=O), 1550(C=N); (DMSO-d6) δ ppm : 3.88 (s, 3H, OCH3), 
6.89–7.89(m, 8H, aromatic), 7.72(s, 1H, N=CH), 9.08(s, 1H, 
Ar–NH), 10.70(s, 1H, CONH); MS: m/z, (M+) 303.74; Anal. 
Calcd for C15H14ClN3O2 : C 59.31 ; H 4.65 ; Cl 11.67 ; N 
13.83 ; O 10.53 Found: C 59.28 ; H 4.66 ;  Cl 11.68 ; N 13.84 
; O 10.54. 
(2E)-N-(2-methoxyphenyl)-2-(4-nitrobenzylidene) 
hydrazinecarboxamide (3q) 
Yield 69%; m.p. 157  _C, IR (KBr) cm
-1
: 3388 (N-H), 1695 
(C=O), 1560(C=N); (DMSO-d6) δ ppm : 3.89 (s, 3H, OCH3), 
6.90–7.91(m, 8H, aromatic), 7.73(s, 1H, N=CH), 9.09(s, 1H, 
Ar–NH), 10.71(s, 1H, CONH); MS: m/z, (M+) 314.29 ; Anal. 
Calcd for C15H14ClN4O4 :  C 57.32 ;  H 4.49 ;  N 17.83 ; O 
20.36 Found: C 57.33 ;  H 4.49 ; N 17.84 ; O 20.37. 
 
(2E)-2-(2,4-dichlorobenzylidene)-N-(2-methoxy 
phenyl)hydrazinecarboxamide(3r)  
Yield 67%; m.p. 181 _C, IR (KBr) cm
-1
: 3388 (N-H), 1695 
(C=O), 1555(C=N); (DMSO-d6) δ ppm : 3.87 (s, 3H, OCH3), 
6.91–7.91(m, 7H, aromatic), 7.72(s, 1H, N=CH), 9.08(s, 1H, 
Ar–NH), 10.70(s, 1H, CONH); MS: m/z, (M+) 338.18; Anal. 
Calcd for C15H13Cl2N3O2 :  C 53.27 ;  H 3.87 ;  Cl 20.97 ; N 
12.43 ; O 9.46  Found: C 53.28 ; H 3.88 ; Cl 20.98 ;  N 12.44 ; 
O 9.47. 
(2E)-2-(2-chlorobenzylidene)-N-(2methoxyphenyl) 
hydrazinecarboxamide (3s) 
Yield 68%; m.p. 142  _C, IR (KBr) cm
-1
: 3398 (N-H), 1705 
(C=O), 1564(C=N); (DMSO-d6) δ ppm : 3.91 (s, 3H, OCH3), 
6.90–7.91(m, 8H, aromatic), 7.75(s, 1H, N=CH), 9.11(s, 1H, 
Ar–NH), 10.73(s1H,CONH); MS: m/z, (M+) 303.74; Anal. 
Calcd for C15H14ClN3O2 C : 59.31 H ; 4.65 ;  Cl  
11.67 ; N 13.83 ; O 10.53 Found: C 59.32 ; H 4.66  ; Cl 11.68 
; N 13.84 ; O 10.54. 
 
Results and discussion 
Chemistry 
The titled compounds (3a-s) were synthesised by following 
the synthetic protocols as mentioned in Scheme 1. 3-chloro-4-
methoxy aniline was reacted with sodium cyanate to get 1-(3-
chloro-4-methoxyphenyl)urea (1) and then it was refluxed 
with hydrazine hydrate to get semicarabazide (2). Reaction of 
compound 2  with different aldehydes and ketones resulted in 
the formation of semicarbazone derivatives. The yields of the 
titled compounds were ranging from 64% to 75% after 
recrystallization with absolute ethanol. The purity of the 
compounds was checked by TLC using eluants benzene: 
aceton (7:3) and elemental analyses. Both the analytical and 
spectral data (IR, 1H NMR) of all the synthesized compounds 
were in full agreement with the proposed structures. In 
general, infra red spectra (IR) revealed N-H, C=O, and C=N at 
3365–3408, 1674–1710, and 1541–1546 cm-1, respectively. 
The 1H NMR spectra showed a singlet at δ  3.79–3.91 ppm 
corresponding to OCH3 group; multiplet at δ 6.82–7.91 ppm 
corresponding to aromatic protons; singlet at δ 8.99–9.11 ppm 
corresponding to Ar–NH; singlet at δ 7.59– 7.75 ppm 
corresponding to N=CH; singlet at δ 10.59–10.73 ppm 
corresponding to CONH. The elemental analysis results were 
within ±0.4% of the theoretical values.  
 
 
 
 
Agrawal and Geyabalan / Indian J. Pharm. Biol. Res., 2017; 5(2):12-17 
 
Research Article  15 
 
Table 1: Compounds and their characteristics 
 
Antimicrobial activity: Synthesized compounds were 
screened for Antimicrobial activities by MIC ( Minimum 
Inhibitory Concentration ) method as follows : 
  
Biological Activity: Procedure 
 
Preparation of inoculum: Three Gram positive (S.aureus, 
S.pneumonia and Bacillus subtilis), three Gram negative 
(E.coli, Klebsiella and Shigella) and two fungal cultures were 
taken for the study. The microbial cultures were periodically 
subcultured in mueller hinton broth in case of bacterial 
cultures and in sabouraud dextrose broth in case of fungal 
cultures. For the study the cultures were grown overnight in 
the respective medium.  
Preparation of test sample: Different concentrations of the 
test samples were dissolved in dimethyl sulphoxide. Various 
concentrations of the test solutions were made in DMSO, like 
1000 µg/ml, 750 µg/ml, 500 µg/ml, 250 µg/ml and 100 µg/ml. 
Standard was also dissolved in DMSO prior to use.All the 
glassware used for the experiments were sterilized by placing 
in a hot air oven at 160 °C for 2 hours and used after reaching 
the room temperature.  
Experimental: For each set of experiments six test tubes were 
sterilized and labelled appropriately. To each set of 
appropriately labelled test tubes 2 ml of sterile Mueller hinton 
broth was added. To this 1 ml of the sample dilution was 
added and was inoculated with the test microorganism. One 
tube was set as a control with 2 ml of medium, 1 ml of 
standard solution (Ciprofloxacin for anti bacterial studies and 
ketoconazole for anti fungal studies) and the inoculums. All 
the process was carried out in an aseptic manner in an aseptic 
chamber. The test tubes were then incubated at 37 °C for 18 to 
24 hours in case for anti bacterial studies. 
 
 
 
 
S.No. Comp. No. R R1 R2 M.P.(oC) Yield% Rf Log p Mol. Wt. 
1. 3a. 3-Chloro-4-
methoxy- 
H 2-Chlorophenyl- 175 73 0.79 4.91 338.189 
2. 3b. 3-Chloro-4-
methoxy- 
H 4-Chlorophenyl- 188 73 0.74 4.97 338.189 
3. 3c. 3-Chloro-4-
methoxy- 
H 2-nitrophenyl- 216 73 0.73 4.32 348.742 
4. 3d. 3-Chloro-4-
methoxy- 
H 4-nitrophenyl- 196 65 0.70 4.14 348.74 
5. 3e. 3-Chloro-4-
methoxy- 
H 2-Hydroxyphenyl- 170 55 0.71 4.19 319.743 
6. 3f. 3-Chloro-4-
methoxy- 
H 4-Hydroxyphenyl- 200 64 0.76 3.97 319.743 
7. 3g. 3-Chloro-4-
methoxy- 
H 4-Methoxyphenyl- 145 68 0.69 4.34 333.770 
8. 3h. 3-Chloro-4-
methoxy- 
H 3,4-dimethoxyphenyl- 188 66 0.68 4.34 363.780 
9. 3i. 3-Chloro-4-
methoxy- 
H 4-N,N-
Dimethylaminophenyl- 
178 65 0.75 4.39 346.811 
10. 3j. 3-Chloro-4-
methoxy- 
CH3 2,4-Dichlorophenyl- 145 64 0.56 4.68 386.660 
11. 3k. 3-Chloro-4-
methoxy- 
CH3 4-hydroxyphenyl 178 63 0.77 3.37 333.770 
12. 3l. 3-Chloro-4-
methoxy- 
CH3 4-Methoxyphenyl- 133 70 0.69 3.90 347.796 
13. 3m. 3-Chloro-4-
methoxy- 
CH3 4-Chlorophenyl- 265 67 0.78 4.50 352.215 
14. 3n. 3-Chloro-4-
methoxy- 
CH3 4-Nitrophenyl 182 67 0.67 3.69 362.768 
15. 3o. 3-Chloro-4-
methoxy- 
CH3 4-Methylphenyl 173 70 0.68 4.19 331.796 
16. 3p. 2-methoxy- H 4-Chlorophenyl 178 69 0.60 4.18 303.743 
17. 3q. 2-methoxy- H 4-Nitrophenyl 158 69 0.61 3.35 314.296 
18. 3r. 2-methoxy- H 2,4-Dichlorophenyl- 182 66 0.73 4.88 338.188 
19. 3s. 2-methoxy- H 2-Chlorophenyl 140 69 0.57 4.12 303.743 
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Table 2: Organism and their concentration 
PR4,PR13,PR16,PR17,PR18           Concentration 
S.no. Organism 1000 mcg 750 
mcg 
500 mcg 250 mcg 100 mcg NB STANDARD 
1 BacillusSubtilis - - - + + + - 
2 E.Coli - - - + + + - 
3 Klebsiella - - - + + + - 
4 S. aureus - - - + + + - 
5 S. pneumonia - - - + + + - 
6 Shigella - - - + + + - 
 
After the incubation period is over, the test tubes are checked 
for growth of micro organisms. The presence of turbidity 
indicates the growth or in other words the inability of the test 
compound to show any inhibitory effect against the test micro 
organisms. If there is no turbidity, that indicated the inhibitory 
effect of the test compound against the tested microbes. 
 52 derivatives were selected for synthesis after a thorough 
study of literature on Semicarbazones and 19 compounds 
(PR1-PR19) were finalised for the research from CADD 
studies . 
 All the 19 compounds were analysed physically and 
spectrally for chemical and structural evaluation. 
 A series (PR1 – PR19) of semicarbazone derivatives were 
subjected for the prediction of molecular properties before 
antimicrobial screening. 
 The compound PR1, PR3, PR5, PR6, PR7, PR8, PR9, 
PR10, PR11, PR12, PR15 and PR 19 does not have any 
inhibitory effect on the tested micro organisms. All the 
three Gram positive and Gram negative organisms tested 
were not inhibited in the tested concentration of the test 
compound.  
  The standard ciprofloxacin has completely inhibited the 
growth of the test organism in all instances. 
 Synthesized Compound PR2 and PR14 have Minimum 
inhibitory Concentration (MIC)   at 750µg/l. 
 Synthesized Compound PR4 , PR13, PR16, PR17 and 
PR18 has Minimum inhibitory Concentration(MIC)  at 
500µg/l. 
Conclusion 
 
A series (3a-s)of semicarbazone derivatives were subjected for 
the prediction of molecular properties before antimicrobial 
screening. All the 16 compounds followed the Lipinski „„Rule 
of Five‟‟. The syntheses of semicarbazone derivatives were 
governed by treating aniline with sodium cyanate to obtain 
phenyl urea (2) which was then refluxed with hydrazine 
hydrate in ethanol to obtain 3-chloro-4-fluorophenyl 
semicarbazides (3) followed by condensation with appropriate 
aldehydes or ketones in the presence of ethanol and sodium 
acetate furnished the titled compounds (3a–s).  
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